These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Safety and efficacy of amlodipine added to hydrochlorothiazide therapy in essential hypertension. Glasser SP; Chrysant SG; Graves J; Rofman B; Koehn DK Am J Hypertens; 1989 Mar; 2(3 Pt 1):154-7. PubMed ID: 2522008 [TBL] [Abstract][Full Text] [Related]
13. A double-blind evaluation of the effect of amlodipine on ambulatory blood pressure in hypertensive patients. Mroczek WJ; Burris JF; Allenby KS J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S79-84. PubMed ID: 2467136 [TBL] [Abstract][Full Text] [Related]
14. Long-term open evaluation of amlodipine versus hydrochlorothiazide in patients with essential hypertension. Rofman BA J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S94-7. PubMed ID: 2467139 [TBL] [Abstract][Full Text] [Related]
15. A comparison of amlodipine, verapamil and placebo in the treatment of mild to moderate hypertension. Amlodipine Study Group. Lorimer AR; Smedsrud T; Walker P; Tyler HM J Hum Hypertens; 1989 Jun; 3(3):191-6. PubMed ID: 2527993 [TBL] [Abstract][Full Text] [Related]
16. Multicenter placebo-controlled comparison of amlodipine and atenolol in mild to moderate hypertension. de Bruijn B; Cocco G; Tyler HM J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S107-9. PubMed ID: 2467117 [TBL] [Abstract][Full Text] [Related]
17. A dose-response study of amlodipine in mild to moderate hypertension. Frick MH; McGibney D; Tyler HM J Intern Med; 1989 Feb; 225(2):101-5. PubMed ID: 2522134 [TBL] [Abstract][Full Text] [Related]
18. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine. Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737 [TBL] [Abstract][Full Text] [Related]
19. First-step treatment of mild to moderate uncomplicated essential hypertension by a new calcium antagonist: nicardipine. Bellet M; Loria Y; Lallemand A J Cardiovasc Pharmacol; 1985; 7(6):1149-53. PubMed ID: 2418302 [TBL] [Abstract][Full Text] [Related]
20. Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension. Messerli FH; Oparil S; Feng Z Am J Cardiol; 2000 Dec; 86(11):1182-7. PubMed ID: 11090788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]